VR program to improve social functioning for people with substance use and mental health disorders

Improving Social Functioning in People With Substance Use and Mental Health Disorders Using Virtual Reality (ROPVR): Study Protocol for a Multi-centre, Pragmatic Randomized Controlled Trial

Not applicable Interventional Sykehuset Innlandet HF · NCT06677515

This trial will try a virtual reality (VR) training program to see if it helps adults in long-term addiction treatment who also have mental health problems improve social and practical functioning.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment102 (estimated)
Ages18 Years to 70 Years
SexAll
SponsorSykehuset Innlandet HF Academic / other
Locations2 sites (Brumunddal and 1 other locations)
Trial IDNCT06677515 on ClinicalTrials.gov

What this trial studies

This is a multi-centre, pragmatic randomized controlled trial comparing a VR-training program with treatment as usual among adults receiving in-patient addiction treatment in South-East Norway. Participants will be randomized to receive twice-weekly VR training sessions for five weeks or continue usual care, with outcomes measured from baseline to six months. Primary outcomes include resilience, quality of life, practical and social functioning, and social participation, and the trial will also analyze cost-effectiveness of the VR program. The VR intervention was developed in prior exploratory and development work and is now being tested in this larger effectiveness trial.

Who should consider this trial

Good fit: Adults (18+) receiving in-patient substance use disorder treatment in specialized addiction units in South-East Norway who can read Norwegian, give informed consent, and are willing and able to attend VR sessions twice weekly for five weeks are eligible.

Not a fit: People with significant visual, auditory, or balance impairments, epilepsy or other conditions that make VR unsafe, current acute psychosis or active suicidal plans, or severe simulation sickness are unlikely to qualify or benefit from the VR training.

Why it matters

Potential benefit: If successful, the VR training could improve resilience, quality of life, daily social skills, and community participation for people in long-term addiction treatment and may be a cost-effective addition to care.

How similar studies have performed: The VR program was developed after prior exploratory and development studies and VR interventions for mental health and substance use have shown promise in smaller trials, but large pragmatic RCT evidence remains limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adults aged 18 years or older receiving in-patient SUD treatment in specialized addiction treatment units in South-East Norway. This may include persons serving prison sentences during in-patient treatment according to the Execution of Sentences Act in Norway
* having the capability to read, understand and sign the Norwegian informed consent form
* willing and able to attend VR training two times a week for 5 weeks

Exclusion Criteria:

* significant visual, auditory, or balance impairment or other diseases affecting safety during VR sessions (e.g., epilepsy)
* current clinically significant severe mental health disorder (e.g., acute episode of psychosis or current active suicidal plans). Persons with psychotic disorders or other severe mental illness are not excluded if their condition is stable.
* severe travel sickness as a proxy for simulation sickness

Where this trial is running

Brumunddal and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Substance Use DisordersMental Disorder
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.